Business Development
Senior Director, Corporate Strategy & Business Development
Summary
Build and lead Hemab’s corporate strategy capability, providing financial and strategic analysis for portfolio and partnership decisions. The role reports to the CFO and develops processes, board materials, and competitive intelligence.
Read by AI
Opportunity summary
About Hemab Hemab is building preventative treatments for serious, underserved bleeding disorders. These are therapies designed to work with the body's own biology and stop bleeds before they start, instead of treating them after they happen. We're patient-first, science-led and clinical-stage - with a pipeline that takes different scientific approaches to different patient needs.
We went public via our 2026 IPO, and we're scaling across two homes:
Cambridge, MA, USA, and Copenhagen, Denmark.
The role
Hemab's pipeline now spans four clinical programs across three molecules and is now at the stage where portfolio and partnership decisions need a dedicated strategy function. This role builds that capability properly: the board-ready analysis, the partnership evaluation, and the competitive intelligence Hemab needs as it moves from single-asset thinking toward managing a full pipeline.
You'll report directly to the CFO and largely define how this function works.
What you'll do
Build and own the financial and strategic analysis behind Hemab's biggest portfolio and partnership decisions. - Prepare board-ready material, including portfolio scenarios, and partnership recommendations that hold up under scrutiny from people who've seen this before1 …
This is a shortened extract from the public vacancy. Follow the original posting for the complete and authoritative description.